CN105148011A - Cancer-curing transdermal cream and preparation method thereof - Google Patents
Cancer-curing transdermal cream and preparation method thereof Download PDFInfo
- Publication number
- CN105148011A CN105148011A CN201510528110.XA CN201510528110A CN105148011A CN 105148011 A CN105148011 A CN 105148011A CN 201510528110 A CN201510528110 A CN 201510528110A CN 105148011 A CN105148011 A CN 105148011A
- Authority
- CN
- China
- Prior art keywords
- parts
- cancer
- transdermal cream
- daily inspection
- curing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses cancer-curing transdermal cream and a preparation method thereof. The cancer-curing transdermal cream is prepared from the following raw materials in part by weight: 10-30 parts of toad, 3-20 parts of veined liparis, 2-18 parts of borax, 4-22 parts of centipede, 15-30 parts of tung oil, 30-60 parts of animal oil, 5-25 parts of shikonin and 8-20 parts of couch grass rhizome. When orally taken anti-cancer drugs work, namely when cancer cells which are attacked and dissolved by the orally taken anti-cancer drugs move to a skin tissue layer of a patient, the cancer-curing transdermal cream can melt the cancer cells accumulated on the skin tissue layer, and the cancer cells are discharged out of the surface layer of the skin of the patient from fine hair pores. Thus, the cancer-curing transdermal cream can effectively make up inefficiency of the anti-cancer drugs in a blind region, and an anti-cancer effect is guaranteed.
Description
Technical field
The present invention relates to the drug world of Therapeutic cancer, especially relating to cancer transdermal cream and preparation method thereof.
Background technology
Cancer is a kind of common frdquently encountered disease, relates to overall systemic disease, and large owing to curing difficulty, the healthy of people and life security in its serious harm.At present, there is the herbal species of Therapeutic cancer, the such as patent No. is ZL200910103788.8, the one cancer treating oral liquid described in Chinese invention patent that name is called " changing cancer treating oral liquid and preparation method thereof ", the patent No. is ZL200910103787.3, name is called a kind of Cancerocidal pill described in Chinese invention patent of " Cancerocidal pill and preparation method thereof ", and they all can improve local symptom and the overall health of patients of patient in the application.Particularly, they can soften hard block, promote that pathological product and inflammatory exudation absorb, and finally reach pathological tissues collapse and dissolving and tumor tissue and soften the effect reduced.Though said medicine in application process can to various cancer (malignant tumor) but have and kill molten effect significantly, but due to the diversity of individual physique, when the cancerous cell of being attacked by medicine and melt often moves to skin tissue layers place, but this medicine can not act on the cancerous cell being gathered in skin tissue layers place further, it is made effectively to discharge in human body, like this, then the therapeutic effect of the anticancer of said medicine and anti-recurrence can be had a strong impact on.Therefore, when using said medicine, also needing to support the use and can assist the medicine dissolving and discharge, and market today there is no corresponding supporting medicine.
Summary of the invention
The object of the invention is the disappearance overcoming prior art, providing cancer transdermal cream and preparation method thereof, by opening the fine hair pore of human body, effectively can melt and discharging and building up in skin tissue layers place cancerous cell, finally reaching effect of anticancer adjuvant.
Object of the present invention is achieved through the following technical solutions:
Change cancer transdermal cream, obtained by the raw material of following portions by weight: Bufo siccus 10 ~ 30 parts, Herba Liparidis nervosae 3 ~ 20 parts, Borax 2 ~ 18 parts, Scolopendra 4 ~ 22 parts, Oleum Verniciae fordii 15 ~ 30 parts, 30 ~ 60 parts, animal oil, Radix Arnebiae (Radix Lithospermi) 5 ~ 25 parts and Rhizoma Imperatae 8 ~ 20 parts.
When the present invention applies, first take Cancerocidal pill on request or change cancer treating oral liquid, but they can carry out killing molten work to malignant tumor, particularly, can hard block be softened, promote that pathological product and inflammatory exudation absorb, lump is slowly relaxed, outwardly, pathological tissues collapse and dissolving, finally make the extensive degeneration of cancerous cell, necrosis.Due to the effect of this kind of endo-medicine, part is attacked by it and the cancerous cell that dissolves can externally move, and thus usually can build up in skin tissue layers place.The present invention is smeared to whole body, and the skin epidermis that lesion especially occurs more answers overbrushing to smear.After the fine hair pore of whole body is opened, patient obviously feels all over the body easily, and at this moment major partization cancer transdermal cream has entered the root of fine hair cell and retained in wherein, the change cancer transdermal cream that then flushable skin surface is unnecessary.When endo-medicine is had an effect, change cancer transdermal cream can melt build up in skin tissue layers cancerous cell, and it to be discharged from fine hair pore, finally reaches effect of anticancer adjuvant.
Case specific as follows:
Yang, sex man, 41 years old age, tumor presence: the two Lung metastases of the postoperative companion of lung cancer chemotherapy.On January 25th, 2014 at Chongqing People's Hospital No. 2's diagnostic result is: superior lobe of right lung lump shadow, size is about 5.1*4.8cm.On January 26th, 2014 rises and starts taking cancer treating oral liquid, every day three times, each serving with 160 ~ 180 grams.Daily inspection in March 1 in 2014, diagnoses: right lung point is shown in tuberosity shadow, and size is about 4.8*4.5cm.Due to taking cancer oral medicine separately to cancerous cell but to kill molten effect not too remarkable, in 2 days March in 2014, while taking cancer treating oral liquid, support the use adopt above-mentioned weighing scale raw material configure change cancer transdermal cream, smear whole body 90 minutes afterflush, five days once.Daily inspection in April 15 in 2014, diagnose to obtain adrenal gland's two tuberosity shadows, size is respectively 3.5*3.1cm.Daily inspection in May 16 in 2014, diagnose to obtain adrenal gland's two tuberosity shadows, size is respectively 2.6*2.5cm.Daily inspection in June 20 in 2014, diagnose to obtain adrenal gland's two tuberosity shadows, size is respectively 1.8*1.7cm.Daily inspection in August 10 in 2014, diagnosis right lung point is shown in a little soft tissue shadow.Checked afterwards and disappear completely, at present, patient is still still living and in good health, without recurrence, in good condition.
Lock so-and-so, sex man, 48 years old age, tumor presence: Lung Cancer Recurrence transfer cervical region.On February 15th, 2013 at Chongqing People's Hospital No. 2's diagnostic result is: the low echo of the several exception of cervical region, differs in size, the most about 1.4*1.0cm.On February 16th, 2013 rises and starts to take Cancerocidal pill, every day three times, each serving with 16 ~ 20 grams.Daily inspection in March 15 in 2013, diagnoses: diagnose to obtain the multiple enlarged lymph nodes in place such as bottom right neck, two hilus pulumonis, differ in size, the most about 1.3*1.0cm.But kill molten effect not too significantly owing to taking separately Cancerocidal pill to cancerous cell, in 16 days March in 2013, while taking Cancerocidal pill, support the use the change cancer transdermal cream adopting above-mentioned weighing scale raw material to configure, smear whole body 90 minutes afterflush, five days once.Daily inspection in April 15 in 2013, diagnoses to obtain the multiple enlarged lymph nodes in place such as bottom right neck, two hilus pulumonis, comparatively before reduces, and existing large person's minor axis is about 1.1cm.Daily inspection in June 28 in 2013, diagnoses to obtain the multiple enlarged lymph nodes in place such as bottom right neck, two hilus pulumonis, comparatively before reduces, and existing large person's minor axis is about 0.7cm.JIUYUE 20 in 2013 daily inspection, the multiple enlarged lymph nodes in place such as bottom right neck, two hilus pulumonis, comparatively before reduce, and existing large person's minor axis is about 0.4cm.December 11 in 2013 daily inspection, diagnosis has a little soft tissue shadow.Checked afterwards and disappear completely, at present, patient is still still living and in good health, without recurrence, in good condition.
Huang, sex female, 66 years old age, tumor presence: the postoperative whole body transfer of carcinoma of endometrium.On October 10th, 2013 at Chongqing People's Hospital No. 2's diagnostic result is: bilateral axillary regions is shown in several lymph node sign, wherein a right side larger about 0.8*0.4cm, the larger about 1.1*0.48cm in left side.On October 12nd, 2013 rises, and starts taking cancer treating oral liquid, every day three times, each serving with 160 ~ 180 grams.Daily inspection in November 10 in 2013, diagnoses: bilateral axillary regions is shown in several lymph node sign, wherein a right side larger about 0.7*0.4cm, the larger about 0.9*0.48cm in left side.Due to taking cancer oral medicine separately to cancerous cell but to kill molten effect not too remarkable, in 11 days November in 2013, while taking cancer treating oral liquid, support the use adopt above-mentioned weighing scale raw material configure change cancer transdermal cream, smear whole body 90 minutes afterflush, five days once.December 10 in 2013 daily inspection, diagnoses to obtain the multiple enlarged lymph node of bilateral axillary regions, comparatively before reduces, wherein a right side larger about 0.5*0.3cm, the larger about 0.6*0.28cm in left side.Daily inspection in February 10 in 2014, diagnoses to obtain the multiple enlarged lymph node of bilateral axillary regions, comparatively before reduces, wherein a right side larger about 0.28*0.11cm, the larger about 0.3*0.14cm in left side.Daily inspection in May 10 in 2014, diagnosis bilateral axillary regions is shown in a little soft tissue shadow.Daily inspection in August 10 in 2014, diagnosis liver, gallbladder, pancreas, spleen, two kidney two-dimensional color doppler sonography no abnormality seen.At present, patient is still still living and in good health, without recurrence, in good condition.
For realizing human body skin to the good absorption changing cancer transdermal cream, preferably, obtained by Bufo siccus 10 ~ 15 parts by weight, Herba Liparidis nervosae 3 ~ 8 parts, Borax 2 ~ 6 parts, Scolopendra 4 ~ 8 parts, Oleum Verniciae fordii 15 ~ 30 parts, 30 ~ 50 parts, animal oil, Radix Arnebiae (Radix Lithospermi) 5 ~ 10 parts and Rhizoma Imperatae 10 ~ 18 parts.
Case specific as follows:
Dong so-and-so, sex man, 45 years old age, tumor presence: recurrence of PHC.Within 2014, December checks in Chongqing People's Hospital No. 2 on the 7th, alpha-fetoprotein: 392.On December 8th, 2014, starts to take Cancerocidal pill medicine, every day three times, each serving with 16 ~ 20 grams.Daily inspection in January 8 in 2015, alpha-fetoprotein: 330.Due to take separately this medicine to cancerous cell but to kill molten effect not too remarkable, in 9 days January in 2015, while taking Cancerocidal pill medicine, support the use the change cancer transdermal cream adopting above-mentioned weighing scale raw material to configure, smear whole body 60 minutes afterflush, five days once.Daily inspection in February 9 in 2015, alpha-fetoprotein: 150.Daily inspection in March 9 in 2015, alpha-fetoprotein: 93.Daily inspection in April 9 in 2015, alpha-fetoprotein: 51.When reexamining afterwards, alpha-fetoprotein maintains in critical field, and current patient's states is good.
Liu so-and-so, sex man, 61 years old age, tumor presence: right lung small cell carcinoma, adrenal gland's metastatic tumo(u)r.Within 2014, December 14th at Chongqing People's Hospital No. 2's diagnostic result is: adrenal gland sees two tuberosity shadows, and size is respectively 3.6*2.6cm, 2.0*1.5cm.December in 2014 rises and starts taking cancer treating oral liquid on the 15th, every day three times, each serving with 160 ~ 180 grams.Daily inspection in January 14 in 2015, diagnoses: adrenal gland's two tuberosity shadows, size is respectively 3.1*2.0cm, 1.8*1.5cm.Due to taking cancer oral medicine separately to cancerous cell but to kill molten effect not too remarkable, in 15 days January in 2015, while taking cancer treating oral liquid, support the use the change cancer transdermal cream adopting above-mentioned weighing scale to configure, smear whole body 60 minutes afterflush, five days once.Daily inspection in February 14 in 2015, diagnose to obtain adrenal gland's two tuberosity shadows, size is respectively 2.4*1.2cm, 1.3*1.4cm.Daily inspection in March 15 in 2015, diagnose to obtain adrenal gland's two tuberosity shadows, size is respectively 1.8*1.2cm, 1.1*1.4cm.Daily inspection in April 25 in 2015, diagnose to obtain adrenal gland's two tuberosity shadows, size is respectively 1.3*0.8cm, 0.9*1.3cm.At present, patient is still still living and in good health, and state progressively takes a turn for the better.
For realizing human body skin to efficient skin function and the lasting pharmacodynamic feature thoroughly of changing cancer transdermal cream, preferably, obtained by Bufo siccus 10 parts by weight, Herba Liparidis nervosae 6 parts, Borax 5 parts, Scolopendra 6 parts, Oleum Verniciae fordii 18 parts, 38 parts, animal oil, Radix Arnebiae (Radix Lithospermi) 10 parts and Rhizoma Imperatae 12 parts.
Case specific as follows:
Swallow, sex man, 72 years old age, tumor presence: intestinal cancer hepatic metastases.On March 10th, 2015 checks in Chongqing People's Hospital No. 2, diagnostic result: CA19-9/120.10; Cytokeratin 19 fragment 20.30; Ferritin 361.90; Carcinoembryonic antigen 1878.00; Alpha-fetoprotein 4.34.On March 10th, 2015, start taking cancer treating oral liquid, every day three times, each serving with 160 ~ 180 grams.Daily inspection in April 9 in 2015, CA19-9/100.28; Cytokeratin 19 fragment 18.16; Ferritin 300.80; Carcinoembryonic antigen 1660.20.Alpha-fetoprotein 3.20.CA19-9/43.83.Due to taking cancer oral medicine separately to cancerous cell but to kill molten effect not too remarkable, in 10 days April in 2015, while taking cancer treating oral liquid, support the use adopt above-mentioned weighing scale raw material configure change cancer transdermal cream, smear whole body 60 minutes afterflush, seven days once.Daily inspection in May 20 in 2015, CA19-9/43.83; Cytokeratin 19 fragment 12.33; Ferritin 139.80; Carcinoembryonic antigen 870.60; Alpha-fetoprotein 3.20.At present, patient is still still living and in good health, in good condition, during the state of an illness progressively takes a turn for the better.
Liu, sex female, 41 years old age, tumor presence: bone metastases of lung cancer.On January 20th, 2015 checks in Chongqing People's Hospital No. 2, diagnostic result: Tumor size is 6.2*5.0cm.On January 20th, 2015, start taking cancer treating oral liquid, every day three times, each serving with 160 ~ 180 grams.Daily inspection in February 21 in 2015, Tumor size is 5.9*4.8cm.Due to taking cancer oral medicine separately to cancerous cell but to kill molten effect not too remarkable, in 13 days February in 2015, while taking cancer treating oral liquid, support the use the change cancer transdermal cream adopting above-mentioned weighing scale raw material to configure, smear whole body 60 minutes afterflush, seven days once.Daily inspection in March 25 in 2015, comparatively before reduces, and Tumor size is 4.2*2.6cm.Daily inspection in June 2 in 2015, Tumor size is 3.0*1.5mm.At present, patient's states is good.
For making human body skin absorption cancer transdermal cream generation effect faster and better, preferably, described animal oil is Adeps Sus domestica or Adeps Bovis seu Bubali or Adeps Caprae seu ovis.
Realize the preparation method of according to claim 1ization cancer transdermal cream, join by weight and get raw material Bufo siccus 10 ~ 30 parts, Herba Liparidis nervosae 3 ~ 20 parts, Borax 2 ~ 18 parts, Scolopendra 4 ~ 22 parts, Oleum Verniciae fordii 15 ~ 30 parts, Radix Arnebiae (Radix Lithospermi) 5 ~ 25 parts and Rhizoma Imperatae 8 ~ 20 parts, this raw material grinding mill is made powder and put into obtaining of the animal oil cancer transdermal cream that parts by weight are 30 ~ 60 parts.In the present invention, above-mentioned raw materials is put into and obtains grey black after animal oil stirs and change cancer transdermal cream in body of paste.
Compared with prior art, the present invention has following beneficial effect: while taking Cancerocidal pill or change cancer treating oral liquid, supporting the use cancer transdermal cream, is smeared to whole body.Like this, the fine hair pore of whole body can be opened, change cancer transdermal cream simultaneously and also the root entering fine hair cell is retained in wherein.When endo-medicine is had an effect, also namely attacked by endo-medicine and the cancerous cell that dissolves when moving to skin tissue layers, change cancer transdermal cream can melt build up in skin tissue layers cancerous cell, and it to be discharged outside skin surface from fine hair pore.Visible, the present invention effectively can make up the incapability of cancer therapy drug for oral administration in blind spot district, ensure that anticancer function.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described in further detail, but embodiments of the present invention are not limited thereto.
Embodiment 1
Change cancer transdermal cream, obtained by the raw material of following portions by weight: Bufo siccus 10 ~ 30 parts, Herba Liparidis nervosae 3 ~ 20 parts, Borax 2 ~ 18 parts, Scolopendra 4 ~ 22 parts, Oleum Verniciae fordii 15 ~ 30 parts, 30 ~ 60 parts, animal oil, Radix Arnebiae (Radix Lithospermi) 5 ~ 25 parts and Rhizoma Imperatae 8 ~ 20 parts.
During the present embodiment application, first take Cancerocidal pill on request or change cancer treating oral liquid, but they can carry out killing molten work to malignant tumor, particularly, can hard block be softened, promote that pathological product and inflammatory exudation absorb, lump is slowly relaxed, outwardly, pathological tissues collapse and dissolving, finally make the extensive degeneration of cancerous cell, necrosis.Due to the effect of this kind of endo-medicine, part is attacked by it and the cancerous cell that dissolves can externally move, and thus usually can build up in skin tissue layers place.The present invention is smeared to whole body, and the skin epidermis that lesion especially occurs more answers overbrushing to smear.After the fine hair pore of whole body is opened, patient obviously feels all over the body easily, and at this moment major partization cancer transdermal cream has entered the root of fine hair cell and retained in wherein, now, and the change cancer transdermal cream that flushable skin surface is unnecessary.When endo-medicine is had an effect, change cancer transdermal cream can melt build up in skin tissue layers cancerous cell, and it to be discharged from fine hair pore, finally reaches effect of anticancer adjuvant.
Case specific as follows:
Yang, sex man, 41 years old age, tumor presence: the two Lung metastases of the postoperative companion of lung cancer chemotherapy.On January 25th, 2014 at Chongqing People's Hospital No. 2's diagnostic result is: superior lobe of right lung lump shadow, size is about 5.1*4.8cm.On January 26th, 2014 rises and starts taking cancer treating oral liquid, every day three times, each serving with 160 ~ 180 grams.Daily inspection in March 1 in 2014, diagnoses: right lung point is shown in tuberosity shadow, and size is about 4.8*4.5cm.Due to taking cancer oral medicine separately to cancerous cell but to kill molten effect not too remarkable, in 2 days March in 2014, while taking cancer treating oral liquid, support the use adopt above-mentioned weighing scale raw material configure change cancer transdermal cream, smear whole body 90 minutes afterflush, five days once.Daily inspection in April 15 in 2014, diagnose to obtain adrenal gland's two tuberosity shadows, size is respectively 3.5*3.1cm.Daily inspection in May 16 in 2014, diagnose to obtain adrenal gland's two tuberosity shadows, size is respectively 2.6*2.5cm.Daily inspection in June 20 in 2014, diagnose to obtain adrenal gland's two tuberosity shadows, size is respectively 1.8*1.7cm.Daily inspection in August 10 in 2014, diagnosis right lung point is shown in a little soft tissue shadow.Checked afterwards and disappear completely, at present, patient is still still living and in good health, without recurrence, in good condition.
Lock so-and-so, sex man, 48 years old age, tumor presence: Lung Cancer Recurrence transfer cervical region.On February 15th, 2013 at Chongqing People's Hospital No. 2's diagnostic result is: the low echo of the several exception of cervical region, differs in size, the most about 1.4*1.0cm.On February 16th, 2013 rises and starts to take Cancerocidal pill, every day three times, each serving with 16 ~ 20 grams.Daily inspection in March 15 in 2013, diagnoses: diagnose to obtain the multiple enlarged lymph nodes in place such as bottom right neck, two hilus pulumonis, differ in size, the most about 1.3*1.0cm.But kill molten effect not too significantly owing to taking separately Cancerocidal pill to cancerous cell, in 16 days March in 2013, while taking Cancerocidal pill, support the use the change cancer transdermal cream adopting above-mentioned weighing scale raw material to configure, smear whole body 90 minutes afterflush, five days once.Daily inspection in April 15 in 2013, diagnoses to obtain the multiple enlarged lymph nodes in place such as bottom right neck, two hilus pulumonis, comparatively before reduces, and existing large person's minor axis is about 1.1cm.Daily inspection in June 28 in 2013, diagnoses to obtain the multiple enlarged lymph nodes in place such as bottom right neck, two hilus pulumonis, comparatively before reduces, and existing large person's minor axis is about 0.7cm.JIUYUE 20 in 2013 daily inspection, the multiple enlarged lymph nodes in place such as bottom right neck, two hilus pulumonis, comparatively before reduce, and existing large person's minor axis is about 0.4cm.December 11 in 2013 daily inspection, diagnosis has a little soft tissue shadow.Checked afterwards and disappear completely, at present, patient is still still living and in good health, without recurrence, in good condition.
Huang, sex female, 66 years old age, tumor presence: the postoperative whole body transfer of carcinoma of endometrium.On October 10th, 2013 at Chongqing People's Hospital No. 2's diagnostic result is: bilateral axillary regions is shown in several lymph node sign, wherein a right side larger about 0.8*0.4cm, the larger about 1.1*0.48cm in left side.On October 12nd, 2013 rises, and starts taking cancer treating oral liquid, every day three times, each serving with 160 ~ 180 grams.Daily inspection in November 10 in 2013, diagnoses: bilateral axillary regions is shown in several lymph node sign, wherein a right side larger about 0.7*0.4cm, the larger about 0.9*0.48cm in left side.Due to taking cancer oral medicine separately to cancerous cell but to kill molten effect not too remarkable, in 11 days November in 2013, while taking cancer treating oral liquid, support the use adopt above-mentioned weighing scale raw material configure change cancer transdermal cream, smear whole body 90 minutes afterflush, five days once.December 10 in 2013 daily inspection, diagnoses to obtain the multiple enlarged lymph node of bilateral axillary regions, comparatively before reduces, wherein a right side larger about 0.5*0.3cm, the larger about 0.6*0.28cm in left side.Daily inspection in February 10 in 2014, diagnoses to obtain the multiple enlarged lymph node of bilateral axillary regions, comparatively before reduces, wherein a right side larger about 0.28*0.11cm, the larger about 0.3*0.14cm in left side.Daily inspection in May 10 in 2014, diagnosis bilateral axillary regions is shown in a little soft tissue shadow.Daily inspection in August 10 in 2014, diagnosis liver, gallbladder, pancreas, spleen, two kidney two-dimensional color doppler sonography no abnormality seen.At present, patient is still still living and in good health, without recurrence, in good condition.
Embodiment 2
The present embodiment has made following restriction further on the basis of embodiment 1: obtained by Bufo siccus 10 ~ 15 parts by weight, Herba Liparidis nervosae 3 ~ 8 parts, Borax 2 ~ 6 parts, Scolopendra 4 ~ 8 parts, Oleum Verniciae fordii 15 ~ 30 parts, 30 ~ 50 parts, animal oil, Radix Arnebiae (Radix Lithospermi) 5 ~ 10 parts and Rhizoma Imperatae 10 ~ 18 parts.In the present embodiment, the change cancer transdermal cream adopting the raw material of above-mentioned scope parts by weight to configure, in a particular application, can accelerate the good absorption of human body skin to it, thus promotes the efficient skin thoroughly of the present embodiment.In the present embodiment, change cancer transdermal cream smearing can complete for about 60 minutes and whole body fine hair pore opened and retains in the work of fine hair cell root.And the change cancer transdermal cream of other scope parts by weight listed in embodiment 1 at least needs to smear more than 90 minutes to the effect reaching the saturating skin of whole body.
Case specific as follows:
Dong so-and-so, sex man, 45 years old age, tumor presence: recurrence of PHC.Within 2014, December checks in Chongqing People's Hospital No. 2 on the 7th, alpha-fetoprotein: 392.On December 8th, 2014, starts to take Cancerocidal pill medicine, every day three times, each serving with 16 ~ 20 grams.Daily inspection in January 8 in 2015, alpha-fetoprotein: 330.Due to take separately this medicine to cancerous cell but to kill molten effect not too remarkable, in 9 days January in 2015, while taking Cancerocidal pill medicine, support the use the change cancer transdermal cream adopting above-mentioned weighing scale raw material to configure, smear whole body 60 minutes afterflush, five days once.Daily inspection in February 9 in 2015, alpha-fetoprotein: 150.Daily inspection in March 9 in 2015, alpha-fetoprotein: 93.Daily inspection in April 9 in 2015, alpha-fetoprotein: 51.When reexamining afterwards, alpha-fetoprotein maintains in critical field, and current patient's states is good.
Liu so-and-so, sex man, 61 years old age, tumor presence: right lung small cell carcinoma, adrenal gland's metastatic tumo(u)r.Within 2014, December 14th at Chongqing People's Hospital No. 2's diagnostic result is: adrenal gland sees two tuberosity shadows, and size is respectively 3.6*2.6cm, 2.0*1.5cm.December in 2014 rises and starts taking cancer treating oral liquid on the 15th, every day three times, each serving with 160 ~ 180 grams.Daily inspection in January 14 in 2015, diagnoses: adrenal gland's two tuberosity shadows, size is respectively 3.1*2.0cm, 1.8*1.5cm.Due to taking cancer oral medicine separately to cancerous cell but to kill molten effect not too remarkable, in 15 days January in 2015, while taking cancer treating oral liquid, support the use the change cancer transdermal cream adopting above-mentioned weighing scale to configure, smear whole body 60 minutes afterflush, five days once.Daily inspection in February 14 in 2015, diagnose to obtain adrenal gland's two tuberosity shadows, size is respectively 2.4*1.2cm, 1.3*1.4cm.Daily inspection in March 15 in 2015, diagnose to obtain adrenal gland's two tuberosity shadows, size is respectively 1.8*1.2cm, 1.1*1.4cm.Daily inspection in April 25 in 2015, diagnose to obtain adrenal gland's two tuberosity shadows, size is respectively 1.3*0.8cm, 0.9*1.3cm.At present, patient is still still living and in good health, and state progressively takes a turn for the better.
Embodiment 3
The present embodiment has made following restriction further on the basis of embodiment 2: obtained by Bufo siccus 10 parts by weight, Herba Liparidis nervosae 6 parts, Borax 5 parts, Scolopendra 6 parts, Oleum Verniciae fordii 18 parts, 38 parts, animal oil, Radix Arnebiae (Radix Lithospermi) 10 parts and Rhizoma Imperatae 12 parts.In the present embodiment, the change cancer transdermal cream adopting above-mentioned weighing scale raw material to configure, in a particular application, can realize human body skin to efficient skin function and the lasting pharmacodynamic feature thoroughly of changing cancer transdermal cream.Like this, fine hair pore can not only be opened rapidly, and when applying, the endurance of drug effect also reaches the strongest state.Typically, for keeping the stable saturating skin state of whole body, supporting the use cancer transdermal cream needs to smear once in five days, and the change cancer transdermal cream adopting the raw material of parts by weight described in the present embodiment obtained then only needs to smear for seven days once to ensure good saturating skin state.
Case specific as follows:
Swallow, sex man, 72 years old age, tumor presence: intestinal cancer hepatic metastases.On March 10th, 2015 checks in Chongqing People's Hospital No. 2, diagnostic result: CA19-9/120.10; Cytokeratin 19 fragment 20.30; Ferritin 361.90; Carcinoembryonic antigen 1878.00; Alpha-fetoprotein 4.34.On March 10th, 2015, start taking cancer treating oral liquid, every day three times, each serving with 160 ~ 180 grams.Daily inspection in April 9 in 2015, CA19-9/100.28; Cytokeratin 19 fragment 18.16; Ferritin 300.80; Carcinoembryonic antigen 1660.20.Alpha-fetoprotein 3.20.CA19-9/43.83.Due to taking cancer oral medicine separately to cancerous cell but to kill molten effect not too remarkable, in 10 days April in 2015, while taking cancer treating oral liquid, support the use adopt above-mentioned weighing scale raw material configure change cancer transdermal cream, smear whole body 60 minutes afterflush, seven days once.Daily inspection in May 20 in 2015, CA19-9/43.83; Cytokeratin 19 fragment 12.33; Ferritin 139.80; Carcinoembryonic antigen 870.60; Alpha-fetoprotein 3.20.At present, patient is still still living and in good health, in good condition, during the state of an illness progressively takes a turn for the better.
Liu, sex female, 41 years old age, tumor presence: bone metastases of lung cancer.On January 20th, 2015 checks in Chongqing People's Hospital No. 2, diagnostic result: Tumor size is 6.2*5.0cm.On January 20th, 2015, start taking cancer treating oral liquid, every day three times, each serving with 160 ~ 180 grams.Daily inspection in February 21 in 2015, Tumor size is 5.9*4.8cm.Due to taking cancer oral medicine separately to cancerous cell but to kill molten effect not too remarkable, in 13 days February in 2015, while taking cancer treating oral liquid, support the use the change cancer transdermal cream adopting above-mentioned weighing scale raw material to configure, smear whole body 60 minutes afterflush, seven days once.Daily inspection in March 25 in 2015, comparatively before reduces, and Tumor size is 4.2*2.6cm.Daily inspection in June 2 in 2015, Tumor size is 3.0*1.5mm.At present, patient's states is good.
Embodiment 4
The basis of the present embodiment any one embodiment in embodiment 1 ~ 3 makes and to have limited further as follows: described animal oil has been Adeps Sus domestica or Adeps Bovis seu Bubali or Adeps Caprae seu ovis.Like this, human body skin can be made to absorb the present invention faster and better, so, be convenient to opening of fine hair pore.
Embodiment 5
Realize the preparation method of the change cancer transdermal cream described in embodiment 1, join by weight and get raw material Bufo siccus 10 ~ 30 parts, Herba Liparidis nervosae 3 ~ 20 parts, Borax 2 ~ 18 parts, Scolopendra 4 ~ 22 parts, Oleum Verniciae fordii 15 ~ 30 parts, Radix Arnebiae (Radix Lithospermi) 5 ~ 25 parts and Rhizoma Imperatae 8 ~ 20 parts, this raw material grinding mill is made powder and put into obtaining of the animal oil cancer transdermal cream that parts by weight are 30 ~ 60 parts.In the present embodiment, above-mentioned raw materials is put into and obtains grey black after animal oil stirs and change cancer transdermal cream in body of paste.
Above content is the further description done the present invention in conjunction with concrete preferred implementation, can not assert that the specific embodiment of the present invention is confined to these explanations.For general technical staff of the technical field of the invention, not departing from other embodiments drawn under technical scheme of the present invention, all should be included in protection scope of the present invention.
Claims (5)
1. change cancer transdermal cream, it is characterized in that: obtained by the raw material of following portions by weight: Bufo siccus 10 ~ 30 parts, Herba Liparidis nervosae 3 ~ 20 parts, Borax 2 ~ 18 parts, Scolopendra 4 ~ 22 parts, Oleum Verniciae fordii 15 ~ 30 parts, 30 ~ 60 parts, animal oil, Radix Arnebiae (Radix Lithospermi) 5 ~ 25 parts and Rhizoma Imperatae 8 ~ 20 parts.
2. according to claim 1ization cancer transdermal cream, is characterized in that: obtained by Bufo siccus 10 ~ 15 parts by weight, Herba Liparidis nervosae 3 ~ 8 parts, Borax 2 ~ 6 parts, Scolopendra 4 ~ 8 parts, Oleum Verniciae fordii 15 ~ 30 parts, 30 ~ 50 parts, animal oil, Radix Arnebiae (Radix Lithospermi) 5 ~ 10 parts and Rhizoma Imperatae 10 ~ 18 parts.
3. according to claim 2ization cancer transdermal cream, is characterized in that: obtained by Bufo siccus 10 parts by weight, Herba Liparidis nervosae 6 parts, Borax 5 parts, Scolopendra 6 parts, Oleum Verniciae fordii 18 parts, 38 parts, animal oil, Radix Arnebiae (Radix Lithospermi) 10 parts and Rhizoma Imperatae 12 parts.
4. according to the change cancer transdermal cream in claims 1 to 3 described in any one, it is characterized in that: described animal oil is Adeps Sus domestica or Adeps Bovis seu Bubali or Adeps Caprae seu ovis.
5. realize the preparation method of according to claim 1ization cancer transdermal cream, it is characterized in that: join by weight and get raw material Bufo siccus 10 ~ 30 parts, Herba Liparidis nervosae 3 ~ 20 parts, Borax 2 ~ 18 parts, Scolopendra 4 ~ 22 parts, Oleum Verniciae fordii 15 ~ 30 parts, Radix Arnebiae (Radix Lithospermi) 5 ~ 25 parts and Rhizoma Imperatae 8 ~ 20 parts, this raw material grinding mill is made powder and put into obtaining of the animal oil cancer transdermal cream that parts by weight are 30 ~ 60 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510528110.XA CN105148011A (en) | 2015-08-25 | 2015-08-25 | Cancer-curing transdermal cream and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510528110.XA CN105148011A (en) | 2015-08-25 | 2015-08-25 | Cancer-curing transdermal cream and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105148011A true CN105148011A (en) | 2015-12-16 |
Family
ID=54789276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510528110.XA Pending CN105148011A (en) | 2015-08-25 | 2015-08-25 | Cancer-curing transdermal cream and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105148011A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106421383A (en) * | 2016-09-28 | 2017-02-22 | 贵州顺康信和肿瘤药物研究有限公司 | Anticancer traditional Chinese medicine composition |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1049789A (en) * | 1990-02-24 | 1991-03-13 | 郭桂芹 | The manufacture method of musk-toad bolus |
| US20030161892A1 (en) * | 2002-02-27 | 2003-08-28 | Mcfarland Connie L. | Topical clotting ointment and method |
| CN102764275A (en) * | 2012-07-02 | 2012-11-07 | 夏永生 | Externally-applied traditional Chinese medicine for treating tumour and preparation method thereof |
| CN104547150A (en) * | 2014-12-17 | 2015-04-29 | 夏永利 | Application of inflammation-diminishing and pain-relieving external medicine as oral agent for treating tumors and ulcerative carbuncles |
-
2015
- 2015-08-25 CN CN201510528110.XA patent/CN105148011A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1049789A (en) * | 1990-02-24 | 1991-03-13 | 郭桂芹 | The manufacture method of musk-toad bolus |
| US20030161892A1 (en) * | 2002-02-27 | 2003-08-28 | Mcfarland Connie L. | Topical clotting ointment and method |
| CN102764275A (en) * | 2012-07-02 | 2012-11-07 | 夏永生 | Externally-applied traditional Chinese medicine for treating tumour and preparation method thereof |
| CN104547150A (en) * | 2014-12-17 | 2015-04-29 | 夏永利 | Application of inflammation-diminishing and pain-relieving external medicine as oral agent for treating tumors and ulcerative carbuncles |
Non-Patent Citations (7)
| Title |
|---|
| 侯士良: "《中药八百种详解》", 31 January 2009 * |
| 倪广林: "紫根汤治疗癌症发热60例分析", 《实用中医内科杂志》 * |
| 江苏新医学院: "《中药大辞典》", 31 July 1977 * |
| 胡小勤等: "《中药学》", 31 January 2014 * |
| 赵建成: "《段凤舞肿瘤积验方》", 30 September 1991 * |
| 金国梁等: "《防癌抗癌中药》", 31 August 2001 * |
| 龙运光等: "《侗族药物方剂学》", 30 September 2009 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106421383A (en) * | 2016-09-28 | 2017-02-22 | 贵州顺康信和肿瘤药物研究有限公司 | Anticancer traditional Chinese medicine composition |
| CN106421383B (en) * | 2016-09-28 | 2018-04-13 | 贵州顺康信和肿瘤药物研究有限公司 | A kind of anticancer traditional Chinese medicinal composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101579416A (en) | Orthopedics plaster and preparation method thereof | |
| CN101745065B (en) | Pharmaceutical composition with effects of resisting cancer and alleviating pain | |
| CN105287441A (en) | Silica gel scar treatment strip and preparation method thereof | |
| CN116392563B (en) | Traditional Chinese medicine composition for treating breast nodules as well as preparation and application thereof | |
| CN108578908A (en) | A kind of graphene Warn uterus paste and preparation method thereof | |
| CN105148011A (en) | Cancer-curing transdermal cream and preparation method thereof | |
| CN104888216B (en) | Delay the zirconium dioxide composite nano materials and preparation method and application of controlled release and CT imaging functions with microwave enhanced sensitivity, chemotherapeutics | |
| CN102614385B (en) | Chinese medicine cataplasm for curing vitiligo and preparation method thereof | |
| CN104208685B (en) | A kind of hollow Ions in nanocrystalline zirconia with tumor microwave heat treatment and CT imaging function and its preparation method and application | |
| CN102631453A (en) | External medicament for treating hyperplasia of mammary glands and ovarian cyst | |
| CN102631645B (en) | Medicine for treating hyperplasia of mammary glands and ovarian cyst | |
| CN103705864B (en) | A kind of steaming bone hot compress plaster for the treatment of cervical vertebra, lumbar spondylosis | |
| CN102274459B (en) | Chinese medicinal preparation for treating uterine fibroid and preparation method thereof | |
| CN102526335B (en) | Externally applied traditional Chinese medicine for treating gout | |
| CN104027767A (en) | Medicine for treating heart qi deficiency, blood stasis and edema syndromes of chronic cardiac failure and preparation method of medicine | |
| CN104623605A (en) | Traditional Chinese medicine capable of treating breast cancer | |
| CN1475243A (en) | External use medicine for treating leucoderma | |
| CN105853635A (en) | Pharmaceutical composition for treating angina pectoris of coronary heart disease | |
| CN104857422B (en) | It treats the composition of colorectal cancer and is used to prepare the purposes for the treatment of large intestine cancer drug | |
| CN100406035C (en) | Chinese medicine preparation for treating protrasion of lumbar intervertebral disc | |
| CN101829167B (en) | Medicine composite for treating cervical erosion and preparation method thereof | |
| CN107441165A (en) | It is exclusively used in treating Chinese medicine composition of angiocardiopathy and preparation method thereof | |
| CN101829253B (en) | Medicine composite for treating cervical erosion and preparation method thereof | |
| CN106728168A (en) | A kind of traditional Chinese medicine for external application for treating eczema, psoriasis and preparation method thereof | |
| CN101829283A (en) | Traditional Chinese medicine for treating lung cancer, gastric cancer, bone marrow cancer and metrocarcinoma and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151216 |